Kembara Xtra - Medicine - Mesothelioma

Kembara Xtra - Medicine - Mesothelioma 
Mesothelioma is a rare, aggressive cancer of the mesothelial or serous tissues that is most commonly detected in the tunica vaginalis (1-2%), peritoneum (20-33%), pleura (65-70%), and pericardium (1-2%).
The main cause of mesothelioma is asbestos inhalation, which most frequently occurs from occupational exposure.

Incidence
The incidence is declining in the United States, but it is rising abroad, especially in Australia and Great Britain.
The incidence of mesothelioma rises with age, peaks in the sixth decade, and 70% of pleural disease affects men. It is anticipated that rates of mesothelioma will begin to decline after 2025 due to reduced exposure and improved knowledge of the process by which mesothelioma develops after exposure to asbestos.
Women are slightly more likely to have peritoneal involvement.
The main risk factor for developing tumors is asbestos exposure, however they have also developed in people with familial Mediterranean fever and diffuse lymphocytic leukemia, prior radiation exposure, or exposure to talc, erionite, or mica.
Prevalence
Every year, 3,300 new instances of mesothelioma are found in the US.


Pathophysiology and Etiology 
Exposure to asbestos, or fibrous minerals made of hydrated magnesium silicate, is the main cause of mesothelioma.
 Inhaled or swallowed asbestos fibers become stuck in pleural or peritoneal membranes, creating changes of irritation and inflammation. There is a long latent period of up to 44 years between exposure and development of mesothelioma.
Genetics
In some families, mesothelioma incidence as well as other malignancies like melanoma are linked to loss of nuclear deubiquitinase BAP1.

Risk Elements 
Asbestos exposure is the main risk factor, and occupational exposures include working with textiles, cement, friction materials, insulation, or shipbuilding.
Radiation exposure, smoking, being close to naturally occurring asbestos deposits, or inhaling other fibrous silicates can all cause malignant mesothelioma. Non-occupational exposures include renovating or demolishing buildings that contain asbestos, being exposed to industrial sources in the neighborhood or natural geologic sources, or coming into contact with the contaminated clothing of asbestos workers.

General Prevention Avoiding asbestos exposure Strict adherence to safety procedures for employees in structures with asbestos Ongoing aggressive cleanup of asbestos-affected structures and dwellings

History When an illness is advanced, symptoms are frequently vague. Weight loss, nocturnal sweats, and generalized weariness could be observed.
Chest discomfort, dyspnea, and cough are the first pulmonary signs of pleural mesothelioma to appear.
Peritoneal illness manifests as weight loss, nausea, anorexia, and a generalized abdominal pain.


clinical assessment 
There are pulmonary signs of pleural effusion, such as diminished breath sounds, dullness to percussion, and asymmetric enlargement of the chest wall.
 Abdominal distension, fluid wave, and discomfort are among the ascites-conforming abdominal findings.

Differential Diagnosis: Inflammatory reactions (empyema, pleural effusion), metastatic tumor from other locations, fibrosarcoma, malignant fibrous histiocytoma, sarcomatoid carcinoma, and synovial sarcoma are among the possible diagnoses for pleural mesothelioma.
The differential diagnosis of peritoneal mesothelioma consists of peritoneal carcinomatosis, serous peritoneal carcinoma, female ovarian carcinoma, lymphomatosis, and tuberculous peritonitis.

Laboratory Results 

Initial examinations (lab, imaging)
There is currently no tumor marker or serum chemistry that can be used to confirm a mesothelioma diagnosis.
Fibulin-3, mesothelin, and osteopontin are biomarkers that may be increased in mesothelioma patients. They do not, however, play a recognized part in making diagnoses or assessing treatment response. The diagnosis of pleural mesothelioma requires tissue.
While closed pleural biopsy and thoracentesis for cytology may be sufficient, more invasive techniques like video-assisted thoracoscopic surgery (VATS) are frequently required to get an appropriate specimen.
Tests in the Future & Special Considerations
Mesothelioma may seed biopsy sites and tracks, which can be avoided by administering prophylactic radiation therapy to the scar or biopsy site.

Other/Diagnostic Procedures
Clinical staging in pleural and peritoneal illness is aided by CT, MRI, PET, or combined PET-CT.
Laparoscopy, mediastinoscopy, and bronchoscopy can all help with the complete surgical staging of pleural illness.
 Endobronchial ultrasonography for staging of pleural illness is being researched.
Interpretation of Tests
Although some centers employ various staging systems, the tumor, node, and metastasis (TNM) system is the most widely utilized.
The Brigham staging method seeks to determine resectability and lymph node involvement, while the Butchart staging system is the earliest and is still used in some regions of the world.

Management For the purpose of patient-specific management planning, a multidisciplinary team should be assembled that includes thoracic surgery, oncology, pathology, pulmonary, and radiology.
The concepts of cancer pain management should guide the assessment and treatment of pain.


First Line of Medicine
Cisplatin coupled with gemcitabine or pemetrexed is associated with a longer median survival in pleural disease than cisplatin alone.
In some populations, the addition of bevacizumab to cisplatin and pemetrexed has been considered as a different treatment option for pleural illness.
Vinflunine is demonstrating some promise as a first-line therapy for pleural illness.
The concentration of the drug in the peritoneum can be increased by hyperthermic intraoperative or early postoperative intraperitoneal chemotherapy, which also lessens systemic side effects. Use fluorouracil, doxorubicin, mitomycin C, cisplatin, and/or paclitaxel.

Second Line: Mitomycin C, vinblastine, cisplatin, and pemetrexed, either alone or in combination with carboplatin, provide palliative effect in the treatment of pleural disease
Systemic treatment options for peritoneal disease may include vinorelbine, gemcitabine, or pemetrexed alone or in combination with cisplatin.


Referral Anger and depression may call for psychological or psychiatric services. Pulmonary, oncology, and surgical follow-up following discharge as necessary.

Further Treatments 
Humanized anti-CB3 AB (OKT3), cytotoxic T lymph (CTL), interferon -2a, and autovaccine are all used in pleural illness immunotherapy.
Vascular endothelial growth factor (anti-VEGF-2) in combination with chemotherapy (2) - Vaccines are being researched. Photodynamic therapy, radiotherapy, and gene therapy are other options.

Procedures involving surgery The function of surgery in treating pleural mesothelioma is not entirely known. The tumor load is decreased by pleurectomy with tumor decortication and extrapleural pneumonectomy, although the impact on mortality is still unclear.
A better prognosis is linked to cytoreductive surgery and radical peritoneal resection.


IV fluids are indicated by degree of hydration upon admission, IV fluids are based on overall clinical condition, nursing is based on clinical status and medical demands, and discharge criteria are based on overall clinical condition

Follow-up, quitting smoking, and influenza and pneumococcal pneumonia vaccinations
Patient Monitoring Keep an eye out for paraneoplastic symptoms such fever, thrombocytosis, thrombosis linked to cancer, hypoglycemia, and the uncommon Coombs-positive hemolytic anemia.

The prognosis depends on the gender, stage, and degree of cytoreduction completion.
Poorly differentiated tumor grade, avoiding surgical resection, getting older, and being a man are all independent indicators of a worse prognosis.
The 5-year survival rate is 63%, with an average survival of 17 to 92 months.

Complications 
progression and relapse, infection, and dysphagia
Aspects of Geriatrics
Significantly higher morbidity and mortality are linked to age >65.

Child Safety Considerations
Pediatric issues are rare because the majority of illnesses develop after the fifth decade of life.
pregnant women's issues
Pregnancy is rarely a problem because the majority of diseases develop after the fifth decade of life.

---